{"id":{"repo_id":"duquesne","oai_identifier":"oai:dsc.duq.edu:etd-2519"},"canonical_url":"https://search.ndltd.org/etd/duquesne/oai:dsc.duq.edu:etd-2519","repository":{"repo_id":"duquesne","name":"Duquesne","base_url":"https://dsc.duq.edu/do/oai/"},"display":{"title":"Computational Modeling of the Binding of Amyloid-Beta to Neprilysin for Facilitating the Development of a Potential Alzheimer's Disease Therapy","abstract":"The zinc metalloprotease neprilysin (NEP) has been shown to degrade small bioactive peptides. Crystal structures of seven NEP-inhibitor complexes and biochemical characterization of NEP activity have highlighted amino acid interactions that are crucial to ligand binding. Studies also indicate that NEP is one of a select group of metalloenzymes that degrade the amyloid-beta peptide (AÃƒÅ¸) in vivo and in situ. Accumulation of neurotoxic AÃƒÅ¸ aggregates in the brain appears to be a causative agent in the pathophysiology of Alzheimer's Disease (AD). For this reason the enzymatic degradation of AÃƒÅ¸ has been studied extensively, but little is known about specific binding interactions underlying NEP degradation of AÃƒÅ¸. Using known crystal structures of NEP, we have conducted comparative computational studies of ligand binding that predict NEP residues Arg 102 and 110 form binding interactions specific to AÃƒÅ¸. These interactions may provide insight for using NEP degradation of AÃƒÅ¸ in AD therapy.","abstract_html":"The zinc metalloprotease neprilysin (NEP) has been shown to degrade small bioactive peptides. Crystal structures of seven NEP-inhibitor complexes and biochemical characterization of NEP activity have highlighted amino acid interactions that are crucial to ligand binding. Studies also indicate that NEP is one of a select group of metalloenzymes that degrade the amyloid-beta peptide (AÃƒÅ¸) in vivo and in situ. Accumulation of neurotoxic AÃƒÅ¸ aggregates in the brain appears to be a causative agent in the pathophysiology of Alzheimer&#x27;s Disease (AD). For this reason the enzymatic degradation of AÃƒÅ¸ has been studied extensively, but little is known about specific binding interactions underlying NEP degradation of AÃƒÅ¸. Using known crystal structures of NEP, we have conducted comparative computational studies of ligand binding that predict NEP residues Arg 102 and 110 form binding interactions specific to AÃƒÅ¸. These interactions may provide insight for using NEP degradation of AÃƒÅ¸ in AD therapy.","abstract_has_math":false,"creators":["Pope, Darrick E."],"institution":null,"degree_name":"MS","degree_level":"Immediate Access","degree_discipline":"Chemistry and Biochemistry","degree_department":null,"school":null,"contributors":["Michael Cascio","Jeffry Madura","Rita Mihailescu"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T07:52:21Z","subjects":["Alzheimer's","Amyloid beta","Computer","model","Molecular dynamic","Neprilysin"],"languages":["English"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://dsc.duq.edu/etd/1507","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://dsc.duq.edu/etd/1507","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://dsc.duq.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adsc.duq.edu%3Aetd-2519","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Michael Cascio","Jeffry Madura","Rita Mihailescu"]},{"key":"dc:creator","label":"Author","values":["Pope, Darrick E."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2023-01-05T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2013-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry and Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Immediate Access"]},{"key":"thesis:degree_name","label":"Degree Name","values":["MS"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Alzheimer's","Amyloid beta","Computer","model","Molecular dynamic","Neprilysin"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dsc.duq.edu/etd/1507"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The zinc metalloprotease neprilysin (NEP) has been shown to degrade small bioactive peptides. Crystal structures of seven NEP-inhibitor complexes and biochemical characterization of NEP activity have highlighted amino acid interactions that are crucial to ligand binding. Studies also indicate that NEP is one of a select group of metalloenzymes that degrade the amyloid-beta peptide (AÃƒÅ¸) in vivo and in situ. Accumulation of neurotoxic AÃƒÅ¸ aggregates in the brain appears to be a causative agent in the pathophysiology of Alzheimer's Disease (AD). For this reason the enzymatic degradation of AÃƒÅ¸ has been studied extensively, but little is known about specific binding interactions underlying NEP degradation of AÃƒÅ¸. Using known crystal structures of NEP, we have conducted comparative computational studies of ligand binding that predict NEP residues Arg 102 and 110 form binding interactions specific to AÃƒÅ¸. These interactions may provide insight for using NEP degradation of AÃƒÅ¸ in AD therapy."]},{"key":"dc:title","label":"Title","values":["Computational Modeling of the Binding of Amyloid-Beta to Neprilysin for Facilitating the Development of a Potential Alzheimer's Disease Therapy"]}]}],"canonical_facts":{"dc:contributor":["Michael Cascio","Jeffry Madura","Rita Mihailescu"],"dc:creator":["Pope, Darrick E."],"dc:date.available":["2023-01-05T08:00:00Z"],"dc:date.created":["2013-01-01T08:00:00Z"],"dc:description.abstract":["The zinc metalloprotease neprilysin (NEP) has been shown to degrade small bioactive peptides. Crystal structures of seven NEP-inhibitor complexes and biochemical characterization of NEP activity have highlighted amino acid interactions that are crucial to ligand binding. Studies also indicate that NEP is one of a select group of metalloenzymes that degrade the amyloid-beta peptide (AÃƒÅ¸) in vivo and in situ. Accumulation of neurotoxic AÃƒÅ¸ aggregates in the brain appears to be a causative agent in the pathophysiology of Alzheimer's Disease (AD). For this reason the enzymatic degradation of AÃƒÅ¸ has been studied extensively, but little is known about specific binding interactions underlying NEP degradation of AÃƒÅ¸. Using known crystal structures of NEP, we have conducted comparative computational studies of ligand binding that predict NEP residues Arg 102 and 110 form binding interactions specific to AÃƒÅ¸. These interactions may provide insight for using NEP degradation of AÃƒÅ¸ in AD therapy."],"dc:identifier":["https://dsc.duq.edu/etd/1507"],"dc:language":["English"],"dc:subject":["Alzheimer's","Amyloid beta","Computer","model","Molecular dynamic","Neprilysin"],"dc:title":["Computational Modeling of the Binding of Amyloid-Beta to Neprilysin for Facilitating the Development of a Potential Alzheimer's Disease Therapy"],"thesis:degree_discipline":["Chemistry and Biochemistry"],"thesis:degree_level":["Immediate Access"],"thesis:degree_name":["MS"]},"updated_at":"2026-11-19T07:52:21Z"}